Pfizer is disappointed with its experimental drug, dacomitinib, which failed in two late-stage studies involving patients who had previously undergone chemotherapy for advanced non-small cell lung cancer (NSCLC).

The lung cancer breathalyzer will detect so-called biomarkers indicative of pulmonary tumor growth.

Under current CT scan screening protocols, nearly 20 percent of lung cancer diagnoses may involve tumors that are too slow-growing to cause any actual damage.

By converting stem cells into functioning lung and airway cells, scientists have taken the first step towards rebuilding a damaged pulmonary system.

The accuracy and efficiency of proton therapy stands to transform radiation treatment for lung cancer patients.

The number of lung cancer patients in Beijing has jumped significantly, due in part to the heavy smog hanging over the city.

A new combination of enzyme inhibiting drugs that causes cancerous cells to digest themselves could soon enter clinical trials.

A simple breath test detecting chemical signatures could soon help physicians screen for lung cancer.

Warning labels describing the health risks of cigarettes and other products may actually increase sales, a new study has found.

GTx's experimental drug enobosarm for lung cancer patients failed in two Phase III clinical trials designed to test its ability to prevent and treat muscle wasting.

The CDC urged an increase in the price of tobacco products after reporting that cigarette smoking among adults dropped slightly from 2005 to 2010.

Smoking rates in the United States declined in the last 5 years, and some people who smoke every day are smoking fewer cigarettes, the Centers for Disease Control and Prevention said Tuesday.